MADDEN DAVID 4
4 · Dicerna Pharmaceuticals Inc · Filed Jun 25, 2018
Insider Transaction Report
Form 4
MADDEN DAVID
Director
Transactions
- Award
Director Stock Option (right to buy)
2018-06-21+33,000→ 33,000 totalExercise: $13.08Exp: 2028-06-21→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]This option vests monthly over 12 months from June 21, 2018 ("Grant Date") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting.